Liquidity remains severely constrained with cash reserves dwindling to $1.8 million, while the firm continues to burn capital to support its legal-centric business model.
| Cash from Operations | -10.22M | -16.12M | -40.02M | -80.64M | 2.25M | -14K |
| Operating CF Margin % | - | -88.34% | -519.44% | -344.3% | 15.38% | -0.1% |
| Operating CF Growth % | 46.61% | 59.72% | 50.37% | -3685.37% | 16164.29% | - |
| Net Income | -719.22M | -1.56B | -835.14M | -401.9M | -33.09M | -24.25M |
| Depreciation & Amortization | 235.18M | 277K | 263K | 424K | 343K | 235K |
| Stock-Based Compensation | -94K | 0 | 830K | 20.05M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | -531K | 0 | 0 |
| Other Non-Cash Items | 897.65M | 1.38B | 759.74M | 361.37M | 25.96M | 21.17M |
| Working Capital Changes | 141.84M | 160.28M | 34.29M | -8.49M | 9.04M | 2.83M |
| Change in Receivables | -78.68M | -78K | 1.78M | -6.2M | 801K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 141.28M | 10.1M | 13.51M | -2.29M | 2.01M | 268K |
| Cash from Investing | -527K | -2.73M | 7.56M | -5.68M | -2.01M | 986K |
| Capital Expenditures | -527K | -525K | -1.74M | -2.98M | -631K | -330K |
| CapEx % of Revenue | 5.37% | 2.88% | 22.61% | 12.74% | 4.31% | 2.38% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 230M |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | -2.2M | 9.3M | -2.7M | 13.37K | -230M |
| Cash from Financing | 14.93M | 19.54M | 29.02M | 99.73M | -10.46M | 9.61M |
| Debt Issued (Net) | 3.08M | 16.48M | 41.4M | 125.76M | 0 | 1.09M |
| Equity Issued (Net) | -699K | 3.06M | -11.42M | 9.19M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | -2.71M | 0 |
| Share Repurchases | 0 | 0 | -11.42M | 0 | 0 | 0 |
| Other Financing | 12.55M | 0 | -958K | -35.21M | -7.75M | 9.61M |
| Net Change in Cash | -2.92M | 695K | -3.45M | 13.42M | -10.21M | 10.58M |
| Free Cash Flow | -10.59M | -16.65M | -41.77M | -83.62M | 1.62M | -344K |
| FCF Margin % | -107.87% | -91.22% | -542.05% | -357.04% | 11.06% | -2.48% |
| FCF Growth % | 63.24% | 60.14% | 50.05% | -5268.05% | 570.35% | - |
| FCF per Share | -0.01 | -16.61 | -117.12 | -845.32 | 13.35 | -0.04 |
| FCF Conversion (FCF/Net Income) | 0.01x | 0.04x | 0.71x | 10.87x | -0.07x | 0.00x |
| Interest Paid | 745K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and litigation uncertainty
As reported in financial statements, MSPR exhibits a profound divergence between net income and operating cash flow, with the company frequently reporting deep net losses while operating cash flow remains erratic and largely insufficient to cover the underlying costs of its aggressive legal-centric business model.
The persistent gap between net income and operating cash flow suggests that the company's accounting earnings are heavily influenced by non-cash items and accruals that do not translate into liquid capital. Investors should monitor this disconnect, as it implies that the firm's reported profitability metrics may not reflect the actual cash-generating capacity of its legal claim portfolio.
Based on recent SEC filings, MSPR's free cash flow trajectory remains highly unstable, oscillating between negative double-digit millions and marginal positive figures, which underscores the inherent unpredictability of relying on legal settlement outcomes to fund ongoing operational requirements and data infrastructure investments.
The lack of a consistent positive free cash flow trend indicates that the company is currently unable to self-fund its operations through core business activities. This volatility warrants further investigation into whether the company can achieve a sustainable cash flow inflection point without continued reliance on external financing.
According to the provided financial data, working capital changes have frequently served as a primary source of cash, suggesting that the company's liquidity position is heavily dependent on the timing of payables and receivables rather than organic cash generation from its healthcare recovery services.
The reliance on working capital shifts to manage cash flow may indicate that the company is stretching its payables or managing collections in a way that masks underlying operational cash burn. This dynamic appears to be a temporary bridge rather than a sustainable mechanism for long-term capital stability.
As indicated by historical financial disclosures, MSPR maintains a high capital intensity relative to revenue, with CAPEX-to-revenue ratios occasionally exceeding 80%, reflecting the significant upfront investment required to build and maintain the proprietary data-parsing platforms necessary for its secondary payer recovery operations.
This high level of capital expenditure suggests that the company is locked into a heavy investment phase that may not yet be yielding proportional returns in cash. The ongoing need for such investment may continue to pressure free cash flow until the company can scale its recovery volume significantly.
Quick answers to the most common questions about buying MSPR stock.
MSP Recovery, Inc. (MSPR) generated $-16.1M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.
MSP Recovery, Inc. (MSPR) reported negative free cash flow of $16.6M in 2024, indicating capital requirements exceeded cash from operations.
MSP Recovery, Inc. (MSPR) spent $0.5M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.